Licences, compulsory stockpiling, monitoring and inspections
The monitoring of the pharmaceutical industry consists of licensing procedures, regular inspections and quality tests of medicinal products placed on the market. Normative regulation and guidance provision are natural parts of this government monitoring.
In Finland medicinal product manufacturer's licences and medicinal product wholesale dealer's licences are issued by Fimea. Under the Medicines Act, medicinal products may only be manufactured industrially by medicinal product manufacturers that have acceptable production facilities and equipment and a licence issued by Fimea. Wholesale trade in medicinal products is also subject to a licence issued by Fimea.
Fimea also monitors compliance with the stockpiling obligation regarding medicinal products. The Act on Compulsory Stockpiling of Medicinal Products (979/2008) applies to medicinal product manufacturers, medicinal product importers, health care units and the Finnish Institute for health and welfare
Questions related to guidance related to GMP-issues of medicinal manufacturers, are to be sent by e-mail to GMP@fimea.fi, wholesale dealer´s issues by e-mail to GDPfirstname.lastname@example.org and stockpiling obligation issues by e-mail to email@example.com.